Table 5.
Effect of HAART During TB treatment Response On The Concentration Of Micronutrients (Month 6)
| Micronutrient Name | HIV+TB+HAART– | HIV+TB+HAART+ | HIV+TB+HAART- vs HIV+TB+HAART+ | HIV+TST– HAART– | HIV+TST– HAART+ | HIV+TST–HAART– vs HIV+TST–HAART+ |
|---|---|---|---|---|---|---|
| Iron(µg/mL) | 0.75(0.44–1.00) | 0.82(0.54–1.48) | 0.4875 | 0.81(0.71–0.88) | 0.66(0.51–1.02) | 0.3111 |
| Vitamin B12 (pg/mL) | 367(264–532) | 381(294–532) | 0.8170 | 400(378–411) | 446(355–587) | 0.4211 |
| Vitamin A (µmol/L) |
1.08(0.59–1.36) | 1.38(1.06–2.02) | 0.1649 | 1.78(1.64–1.85) | 1.78(1.15–1.99) | 0.7655 |
Notes: Median (interquartile range) micronutrient values are shown. Significant differences between HAART treated and HAART untreated HIV+TB+ patients and between HAART treated and HAART untreated HIV+TST– patients at completion of treatment (Month 6) were determined using the Wilcoxon signed-rank test. P-values ≤ 0.05 for the comparison between the groups are indicated in bold.